A LinkedIn post from AcuityMD highlights internal data suggesting a significant migration of endoscopic colorectal procedures from hospitals to ambulatory surgery centers in 2024. The post cites nearly 9 million such procedures at ASCs, representing an estimated 50% increase since 2018 and indicating that ASCs now handle the majority of these cases.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn content also notes that ASC procedures can be more than 60% less expensive than hospital-based care, which may support payer and patient demand for lower-cost settings. For investors, the post implies that MedTech companies focused solely on hospital volumes risk missing growth opportunities as procedure volume shifts to ASCs.
The post further suggests that tracking site-of-care changes could be commercially important for medical device and diagnostics firms that rely on targeted physician engagement. AcuityMD promotes a report on these trends, indicating an effort to position its data platform as a tool for identifying high-growth ASC markets and aligning commercial resources with evolving utilization patterns.

